ici 118551 has been researched along with esmolol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Selvam, B; Tikhonova, IG; Wereszczynski, J | 1 |
| Funao, T; Kawai, S; Matsuura, T; Nishikawa, K; Yamada, T | 1 |
2 other study(ies) available for ici 118551 and esmolol
| Article | Year |
|---|---|
Comparison of dynamics of extracellular accesses to the β(1) and β(2) adrenoceptors binding sites uncovers the potential of kinetic basis of antagonist selectivity.
Topics: Adrenergic beta-Antagonists; Binding Sites; Drug Design; Humans; Molecular Dynamics Simulation; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2 | 2012 |
Neuropathic pain attenuates ischemia reperfusion injury through β2-adrenergic pathway.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Animals; Hemodynamics; Hyperalgesia; Isolated Heart Preparation; Ligation; Male; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocytes, Cardiac; Neuralgia; Phosphotransferases; Propanolamines; Protective Factors; Rats; Reperfusion Injury; Spinal Cord | 2017 |